Jonas A. Gylys

539 total citations
22 papers, 398 citations indexed

About

Jonas A. Gylys is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Jonas A. Gylys has authored 22 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cellular and Molecular Neuroscience, 7 papers in Molecular Biology and 6 papers in Organic Chemistry. Recurrent topics in Jonas A. Gylys's work include Neurotransmitter Receptor Influence on Behavior (6 papers), Pharmacological Receptor Mechanisms and Effects (5 papers) and Behavioral and Psychological Studies (4 papers). Jonas A. Gylys is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (6 papers), Pharmacological Receptor Mechanisms and Effects (5 papers) and Behavioral and Psychological Studies (4 papers). Jonas A. Gylys collaborates with scholars based in United States, Germany and United Kingdom. Jonas A. Gylys's co-authors include J P Buyniski, M. E. Bierwagen, R L Cavanagh, Anthony W. Pircio, Hugh A. Tilson, Rachael Wright, R. A. Partyka, Alexander T. Shulgin, Henry G. Howell and R. R. Crenshaw and has published in prestigious journals such as Annals of the New York Academy of Sciences, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Jonas A. Gylys

22 papers receiving 356 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jonas A. Gylys United States	11	144	104	65	62	57	22	398
Akira Horita United States	13	232 1.6×	173 1.7×	84 1.3×	66 1.1×	48 0.8×	33	526
Irwin H. Slater United States	12	197 1.4×	229 2.2×	92 1.4×	52 0.8×	92 1.6×	23	654
John M. Stavorski United States	11	200 1.4×	219 2.1×	132 2.0×	65 1.0×	60 1.1×	16	593
Lars Flataker United States	13	184 1.3×	127 1.2×	146 2.2×	60 1.0×	77 1.4×	23	516
Jens‐Jørgen Larsen Denmark	15	260 1.8×	189 1.8×	145 2.2×	50 0.8×	54 0.9×	26	563
E.B. Sigg United States	11	153 1.1×	111 1.1×	78 1.2×	37 0.6×	65 1.1×	17	368
C Larousse France	11	178 1.2×	151 1.5×	20 0.3×	52 0.8×	108 1.9×	56	549
William H. Funderburk United States	12	206 1.4×	113 1.1×	47 0.7×	62 1.0×	52 0.9×	31	430
C. C. Toh Singapore	9	146 1.0×	127 1.2×	124 1.9×	29 0.5×	54 0.9×	16	553
J.W. Lewis United States	10	211 1.5×	188 1.8×	168 2.6×	49 0.8×	56 1.0×	15	385

Countries citing papers authored by Jonas A. Gylys

Since Specialization

Citations

This map shows the geographic impact of Jonas A. Gylys's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonas A. Gylys with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonas A. Gylys more than expected).

Fields of papers citing papers by Jonas A. Gylys

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonas A. Gylys. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonas A. Gylys. The network helps show where Jonas A. Gylys may publish in the future.

Co-authorship network of co-authors of Jonas A. Gylys

This figure shows the co-authorship network connecting the top 25 collaborators of Jonas A. Gylys. A scholar is included among the top collaborators of Jonas A. Gylys based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonas A. Gylys. Jonas A. Gylys is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Eison, Arlene S., et al.. (1993). 5-HT-Dependent myoclonus in guinea pigs: Mediation through 5-HT1A-5-HT2 receptor interaction. Brain Research Bulletin. 30(5-6). 687–689. 12 indexed citations

Eison, Arlene S., et al.. (1993). Effects of BMY 33462, a selective and potent serotonin type‐3 receptor antagonist, on mesolimbic dopamine‐mediated behavior. Drug Development Research. 29(1). 18–24. 4 indexed citations

Monković, Ivo & Jonas A. Gylys. (1990). 7 Developments in the Antiemetic Area: Chemistry, Pharmacology and Therapy. Progress in medicinal chemistry. 27. 297–323. 3 indexed citations

Gylys, Jonas A., et al.. (1988). BMY-25801, an antiemetic agent free of D2-dopamine receptor antagonist properties.. Journal of Pharmacology and Experimental Therapeutics. 244(3). 830–837. 35 indexed citations

Wright, Rachael, et al.. (1987). Disease modifying activity of HWA 486 in rat adjuvant-induced arthritis. Inflammation Research. 21(3-4). 241–243. 23 indexed citations

Gylys, Jonas A. & J. S. Gidda. (1986). Radiation induced emesis in ferrets an experimental model of emesis. 2. 1446. 6 indexed citations

Tilson, H.A., et al.. (1977). Behavioral comparisons of R-2-amino-1-(2,5-dimethoxy-4-methylphenyl) butane (BL-3912A) with R-DOM and S-Amphetamine. Psychopharmacology. 51(2). 169–173. 8 indexed citations

Tilson, Hugh A., et al.. (1977). Behavioral suppressant effects of clonidine in strains of normotensive and hypertensive rats. European Journal of Pharmacology. 43(2). 99–105. 51 indexed citations

Tilson, Hugh A., et al.. (1977). Further studies on BL-3912A: Effects on avoidance behavior of rats with low baselines and on reaction thresholds to electric footshock. Pharmacology Biochemistry and Behavior. 6(6). 627–630. 6 indexed citations

10.

Howell, Henry G., et al.. (1977). ChemInform Abstract: PHENYLALKYLAMINES WITH POTENTIAL PSYCHOTHERAPEUTIC UTILITY. 1. 2‐AMINO‐1‐(2,5‐DIMETHOXY‐4‐METHYLPHENYL)BUTANE. Chemischer Informationsdienst. 8(16). 1 indexed citations

11.

Cavanagh, R L, Jonas A. Gylys, & M. E. Bierwagen. (1976). Antitussive properties of butorphanol.. PubMed. 220(2). 258–68. 23 indexed citations

12.

Howell, Henry G., et al.. (1976). Phenylalkylamines with potential psychotherapeutic utility. 1. 2-Amino-1-(2,5-dimethoxy-4-methylphenyl)butane. Journal of Medicinal Chemistry. 19(12). 1400–1404. 37 indexed citations

13.

Pircio, Anthony W., Jonas A. Gylys, R L Cavanagh, J P Buyniski, & M. E. Bierwagen. (1976). The pharmacology of butorphanol, a 3,14-dihydroxymorphinan narcotic antagonist analgesic.. PubMed. 220(2). 231–57. 97 indexed citations

14.

Pircio, Anthony W. & Jonas A. Gylys. (1975). Oxilorphan (l-N-cyclopropylmethyl-3,14-dihydroxymorphinan): a new synthetic narcotic antagonist.. Journal of Pharmacology and Experimental Therapeutics. 193(1). 23–34. 5 indexed citations

15.

Gylys, Jonas A., et al.. (1975). Quinuclidine chemistry. 3. .beta.-cis-2-(4'-Chlorobenzhydryl)-3-quinuclidinol, a new central nervous system stimulant. Importance of the benzhydryl configuration. Journal of Medicinal Chemistry. 18(1). 71–74. 10 indexed citations

16.

Tilson, H.A., T. G. Baker, & Jonas A. Gylys. (1975). A comparison of the discriminative stimulus properties of R-2,5-dimethoxy-4-methylamphetamine (R-DOM) and S-amphetamine in the rat. Psychopharmacology. 44(3). 225–228. 10 indexed citations

17.

Monković, Ivo, et al.. (1973). Substituted tetrahydrofurfurylamines as potential antidepresaants. Journal of Medicinal Chemistry. 16(4). 403–407. 13 indexed citations

18.

Biel, John H., et al.. (1970). Tranquilizing drugs. Carbamates of 4-(4-hydroxypiperidino)-4'-fluorobutyrophenone and analogs. Journal of Medicinal Chemistry. 13(6). 1230–1232. 1 indexed citations

19.

Gylys, Jonas A., et al.. (1963). PHARMACOLOGICAL AND TOXICOLOGICAL PROPERTIES OF 2‐METHYL‐3‐PIPERIDINOPYRAZINE, A NEW ANTIDEPRESSANT*. Annals of the New York Academy of Sciences. 107(3). 899–913. 18 indexed citations

20.

Gylys, Jonas A., et al.. (1962). CHLORPHENTERMINE, A NEW ANORECTIC AGENT. Journal of Pharmacology and Experimental Therapeutics. 137(3). 365–373. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact